Full text

Turn on search term navigation

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

A key part of any effort to ensure informed health care decision-making among the public is access to reliable and relevant health-related information. We conducted focus groups with women from three generations across the Baltimore–Washington metropolitan area to explore their information-seeking motivations, perceptions, challenges, and preferences regarding three FDA-regulated products: drugs, vaccines, and medical devices. The youngest generation discussed seeking health information for their children; the other two sought information for their own needs. All participants noted that finding health information appropriate to their reading level was a challenge, as was identifying reliable sources of information. All generations identified in-person and live interactions as their preferred method of communication and health care providers as their preferred source for information. All three generations recognized the usefulness of websites, and the two older generations acknowledged the advantages of brochures. Our findings suggest approaches the FDA could consider to improve communications: (a) supporting in-person and live health information interactions; (b) leveraging the agency’s standing with the public to highlight it as a leading source of validated health information; (c) increasing the FDA website’s visibility in internet searches and making its navigation easier; and (d) using multi-pronged approaches and media for various audiences.

Details

Title
Women’s Health Information-Seeking Experiences and Preferences for Health Communications on FDA-Regulated Products: A Qualitative Study in Urban Area
Author
Abdelwadoud, Moaz 1   VIAFID ORCID Logo  ; Huang, Jennifer 2 ; Villalonga-Olives, Ester 3   VIAFID ORCID Logo  ; dosReis, Susan 3 ; Jansky, Liz 2 ; Mullins, C Daniel 3   VIAFID ORCID Logo  ; Kusinitz, Marc 4 ; Ovelmen, Heather 5 ; Ju, Julia 4 

 Department of Global and Environmental Health, New York University, New York, NY 10003, USA; [email protected] 
 Westat, Rockville, MD 20850, USA; [email protected] (J.H.); [email protected] (L.J.) 
 Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA; [email protected] (E.V.-O.); [email protected] (S.d.) 
 United States Food and Drug Administration, Silver Spring, MD 20993, USA; [email protected] (M.K.); [email protected] (J.J.) 
 National Institutes of Health, Bethesda, MD 20892, USA; [email protected] 
First page
321
Publication year
2024
Publication date
2024
Publisher
MDPI AG
ISSN
1661-7827
e-ISSN
1660-4601
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3002416399
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.